Review of Covaxin underway, expect a recommendation within 24 hours: WHO
The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid 19 vaccine
Biological E hopes to roll out COVID vaccine by November-end
Biological E’s anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase-II/III…
Modi interacts with domestic vaccine manufacturers
The vaccine manufacturers appreciated the vision and leadership of the Prime Minister in providing continuous guidance and support…
WHO urges G20 to step up COVID-19 vaccine donations to the south
"The @g20org countries must fulfil their dose-sharing commitments immediately," Tedros Adhanom Ghebreyesus, Director-General, WHO,…
Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine
First results from any randomised, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6 per…
Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate…
VLA2001 was well-tolerated, demonstrating a statistically significant better tolerability profile compared to active comparator…
mRNA COVID jabs as second dose may generate robust immune response: Lancet study
The study, published in the journal The Lancet Regional Health - Europe, points out the high effectiveness of mix-and-match…
Pfizer/BioNTech submit data to EMA for children’s COVID-19 vaccine
Although the vaccine is currently not allowed for that age group, it has been authorised for use in children over 12 years of age…
Over 30 countries agree on mutual recognition of COVID-19 vaccine certificates with India, reveal…
The countries that have agreed on mutual recognition with India include the UK, France, Germany, Nepal, Belarus, Lebanon, Armenia,…
Bharat Biotech awaits regulatory approvals to launch Covaxin for children
The SEC on COVID-19 examined the data and deliberated on the EUA application yesterday